Amicus Therapeutics
FOLD
S$7.87
Share price
0.99%
Change (1 day)
-42.03%
Change (1 year)
Categories
EPS for Amicus Therapeutics (FOLD)
EPS in 2025 (TTM): S-$0.40
According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$0.39. In 2014 the company made an earnings per share (EPS) of S-$1.20.
EPS history for Amicus Therapeutics from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | S-$0.40 | |
| 2014 | S-$1.20 | |
| 2012 | S-$1.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Biogen BIIB | S$13.07 | -3,486.67% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | S$3.54 | -1,016.67% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | S-$1.03 | 166.67% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$2.01 | -619.93% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | S-$0.66 | 70.00% | 🇺🇸 USA |
 Novo Nordisk NVO | S$4.29 | -1,212.28% | 🇩🇰 Denmark |